Samuel J S Rubin

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Molecular Docking

Ulcerative Colitis

Top Venues

International journal of molecular sciences

Journal of clinical and translational science

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Mulate Zerihun, Samuel J S Rubin, Shmuel Silnitsky, Nir Qvit
An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein Interactions. International journal of molecular sciences 24 (24) (2023)
Mulate Zerihun, Samuel J S Rubin, Shmuel Silnitsky, Nir Qvit
An Update on Protein Kinases as Therapeutic Targets-Part II: Peptides as Allosteric Protein Kinase C Modulators Targeting Protein-Protein Interactions. International journal of molecular sciences 24 (24) (2023)
Shmuel Silnitsky, Samuel J S Rubin, Mulate Zerihun, Nir Qvit
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases. International journal of molecular sciences 24 (24) (2023)
Shmuel Silnitsky, Samuel J S Rubin, Mulate Zerihun, Nir Qvit
An Update on Protein Kinases as Therapeutic Targets-Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases. International journal of molecular sciences 24 (24) (2023)
Se Eun Ha, Brian G Jorgensen, Lai Wei, Byungchang Jin, Min-Seob Kim, Sandra M Poudrier, Uday C Ghoshal, Han-Seung Ryu, Hannah Zogg, Sei Kim, Gain Baek, Masaaki Kurahashi, Moon-Young Lee, Yong-Sung Kim, Suck-Chei Choi, Kent C Sasse, Samuel J S Rubin, Andres Gottfried-Blackmore, Laren Becker, Aida Habtezion, Kenton M Sanders, Seungil Ro
Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα + Cells Is a New Marker for Inflammatory Bowel Disease. International journal of molecular sciences 23 (9) (2022)
Samuel J S Rubin, Raoul S Sojwal, John Mark Gubatan, Stephan R Rogalla
The Tumor Immune Microenvironment in Pancreatic Ductal Adenocarcinoma: Neither Hot nor Cold. Cancers 14 (17) (2022)
John Mark Gubatan, Kian Keyashian, Samuel J S Rubin, Jenny Wang, Cyrus A Buckman, Sidhartha Sinha
Anti-Integrins for the Treatment of Inflammatory Bowel Disease: Current Evidence and Perspectives. Clinical and experimental gastroenterology 14 (2021)
Samuel J S Rubin, Samuel R Falkson, Nicholas R Degner, Catherine A Blish
Safety of ACE-I and ARB medications in COVID-19: A retrospective cohort study of inpatients and outpatients in California. Journal of clinical and translational science 5 (1) (2021)
Andres Gottfried-Blackmore, Samuel J S Rubin, Lawrence Bai, Sheun Aluko, Yujun Yang, Walter Park, Aida Habtezion
Effects of processing conditions on stability of immune analytes in human blood. Scientific reports 10 (1) (2020)
Samuel J S Rubin, Samuel R Falkson, Nicholas R Degner, Catherine Blish
Clinical characteristics associated with COVID-19 severity in California. Journal of clinical and translational science 5 (1) (2020)
Samuel J S Rubin, Lawrence Bai, Yeneneh Haileselassie, Gotzone Garay, Chohee Yun, Laren Becker, Sarah E Streett, Sidhartha R Sinha, Aida Habtezion
Mass cytometry reveals systemic and local immune signatures that distinguish inflammatory bowel diseases. Nature communications 10 (1) (2019)